BRAX:CC News and Press, Braxia Scientific Corp. From 11/01/22

Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders Canada NewsWire TORONTO , Nov. 1, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical res...

KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers Canada NewsWire Patients Can Download the KetaMD Mobile App and Sign Up Anytime Through KetaMD.com to Access Keta...

Braxia Scientific Announces Board Appointment Canada NewsWire TORONTO , Sept. 21, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) a medical research and telemedicine company with clinics p...

Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home Canada NewsWire TORONTO , Sept. 12, 2022 /CNW Telbec/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company") (CSE: BRAX) (OTC: BRA...

Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 Canada NewsWire TORONTO , Sept. 9, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: ...

Braxia Scientific Corp. (CSE: BRAX, OTC: BRAXF) posted steady growth in its fiscal first quarter, good news in its quest for profitability after its recent acquisition of Florida-based KetaMD . The Canadian research and telehealth company filed its financial and operationa...

Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), acquired KetaMD , Inc. in a bid to expand ketamine-based psychedelic treatment for depression and other mental health challenges. The overall value of the deal is $6.2 million in a combination of common shares and convertible n...

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S. Canada NewsWire TORONTO , Aug. 3, 2022 /CNW/ - Braxia Scientific Corp. ...

Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results Canada NewsWire Achieved Health Canada Special Access Program approval to provide psilocybin-assisted therapy for depression in Ontario Completed more than 6,000 treatments to date; expa...

Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Indu...